PT  - JOURNAL ARTICLE
AU  - Ntawukuriryayo, Jovial Thomas
AU  - VanderZanden, Amelia
AU  - Amberbir, Alemayehu
AU  - Teklu, Alula
AU  - Huda, Fauzia Akhter
AU  - Maskey, Mahesh
AU  - Sall, Mohamadou
AU  - Garcia, Patricia J
AU  - Subedi, Raj Kumar
AU  - Felix, Sayinzoga
AU  - Hirschhorn, Lisa R
AU  - Binagwaho, Agnes
TI  - Inequity in the face of success: Understanding geographic and wealth-based equity in success of facility-based delivery for under-5 mortality reduction in six countries
AID  - 10.1101/2023.05.29.23290665
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.29.23290665
4099  - http://medrxiv.org/content/early/2023/06/04/2023.05.29.23290665.short
4100  - http://medrxiv.org/content/early/2023/06/04/2023.05.29.23290665.full
AB  - Background Between 2000-2015, many low- and middle-income countries (LMICs) implemented evidence-based interventions (EBIs) known to reduce under-5 mortality (U5M). Even among LMICs successful in reducing U5M, this drop was unequal subnationally, with varying success in EBI implementation. Building on mixed methods multi-case studies of six LMICs (Bangladesh, Ethiopia, Nepal, Peru, Rwanda, and Senegal) leading in U5M reduction, we describe geographic and wealth-based equity in facility-based delivery (FBD), a critical EBI to reduce neonatal mortality which requires a trusted and functional health system, and compare the implementation strategies and contextual factors which influenced success or challenges within and across the countries.Methods To obtain equity gaps in FBD coverage and changes in absolute geographic and wealth-based equity between 2000-2015, we calculated the difference between the highest and lowest FBD coverage across subnational regions and in the FBD coverage between the richest and poorest wealth quintiles. We extracted and compared contextual factors and implementation strategies associated with reduced or remaining inequities from the country case studies.Results The absolute geographic and wealth-based equity gaps decreased in three countries, with greatest drops in Rwanda – decreasing from 50% to 5% across subnational regions and from 43% to 13% across wealth quintiles. The largest increases were seen in Bangladesh – from 10% to 32% across geography – and in Ethiopia – from 22% to 58% across wealth quintiles. Facilitators to reducing equity gaps across the six countries included leadership commitment and culture of data use; in some countries, community or maternal and child health insurance was also an important factor (Rwanda and Peru). Barriers across all the countries included geography, while country-specific barriers included low female empowerment subnationally (Bangladesh) and cultural beliefs (Ethiopia). Successful strategies included building on community health worker (CHW) programs, with country-specific adaptation of pre-existing CHW programs (Rwanda, Ethiopia, and Senegal) and cultural adaptation of delivery protocols (Peru). Reducing delivery costs was successful in Senegal, and partially successful in Nepal and Ethiopia.Conclusion Variable success in reducing inequity in FBD coverage among countries successful in reducing U5M underscores the importance of measuring not just coverage but also equity. Learning from FBD interventions shows the need to prioritize equity in access and uptake of EBIs for the poor and in remote areas by adapting the strategies to local context.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the Gates Ventures and Bill & Melinda Gates Foundation [OPP1191491].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Rwanda National Ethics Committee and Northwestern University determined the research to be non-human subjects study. Each country case study was reviewed by and received approval from in-country Ethics Review Committees (Ethiopia, PM23/281; Peru, 104276; Bangladesh, PR-18074; Nepal, 165-2018; Senegal, SEN18/33; Rwanda, 132/RNEC/2017).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.CBHICommunity-based health insuranceCHWCommunity health workerDHSDemographic and Health SurveyEBIEvidence-based interventionFBDFacility-based deliveryKIKey informantKIIKey informant interviewLMICLow- and middle-income countryMDGsMillennium Development GoalsMOHMinistry of HealthNMRNeonatal mortalityPARSALUDPrograma de Apoyo a la Reforma del Sector SaludSISSeguro Integral de SaludU5Under 5U5MUnder-5 mortalityWHOWorld Health Organization